News

First Lady Jill Biden, PhD, met with top UC San Francisco cancer leaders during a visit Friday to hear about UCSF’s breast cancer research and progress on the National Cancer Moonshot. The visit was timed to mark Breast Cancer Awareness Month in October. Hosted by Alan Ashworth, PhD, FRS, president

The National Institutes of Health is launching a program to better understand the function of every human gene and generate a catalog of the molecular and cellular consequences of inactivating each gene. The Molecular Phenotypes of Null Alleles in Cells (MorPhiC) program, managed by the National

Bioscience discovery is not a solo pursuit. Confronted with mountains of genomic data, it takes a team of researchers with complementary expertise to glean gemlike insights. On a sunny Friday, teams of aspiring young scientists gathered in the Clinical Sciences building at Parnassus Heights, looking

UCSF Health is recruiting patients for the only FDA-approved study of the use of single port robotic technology for colorectal surgery in the United States. UC San Francisco clinical investigators Ankit Sarin, MD, FACS, and Hueylan Chern, MD, initiated the study which will evaluate whether single

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now, UC San Francisco researchers have developed a drug that overcomes some of these barriers, marking cancer cells for destruction by

UC San Francisco hosted Queen Máxima of the Netherlands on Tuesday, as part of a Dutch trade mission to California. Two Dutch cancer experts at UCSF, Jeroen Roose, PhD, and Laura van ‘t Veer, PhD, discussed their work and how it has been supported by the entrepreneurial culture at UCSF and the Bay